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Abstract
Background: Cerebral malaria (CM) is the most severe outcome of Plasmodium falciparum infection and a major cause of
death in children from 2 to 4 years of age. A hospital based study in Ghana showed that P. falciparum induces eosinophilia
and found a significantly higher serum level of eosinophil cationic protein (ECP) in CM patients than in uncomplicated
malaria (UM) and severe malaria anemia (SA) patients. Single nucleotide polymorphisms (SNPs) have been described in the
ECP encoding-gene (RNASE3) of which the c.371G.C polymorphism (rs2073342) results in an arginine to threonine amino
acid substitution p.R124T in the polypeptide and abolishes the cytotoxicity of ECP. The present study aimed to investigate
the potential association between polymorphisms in RNASE3 and CM.
Methodology/Principal Findings: The RNASE3 gene and flanking regions were sequenced in 206 Ghanaian children
enrolled in a hospital based malaria study. An association study was carried out to assess the significance of five SNPs in CM
(n = 45) and SA (n = 56) cases, respectively. The two severe case groups (CM and SA) were compared with the non-severe
control group comprising children suffering from UM (n= 105). The 371G allele was significantly associated with CM
(p= 0.00945, OR = 2.29, 95% CI = 1.22–4.32) but not with SA. Linkage disequilibrium analysis demonstrated significant
linkage between three SNPs and the haplotype combination 371G/*16G/*94A was strongly associated with susceptibility to
CM (p = 0.000913, OR = 4.14, 95% CI = 1.79–9.56), thus, defining a risk haplotype. The RNASE3 371GG genotype was found
to be under frequency-dependent selection.
Conclusions/Significance: The 371G allele of RNASE3 is associated with susceptibility to CM and forms part of a risk
associated haplotype GGA defined by the markers: rs2073342 (G-allele), rs2233860 (G-allele) and rs8019343 (A-allele)
respectively. Collectively, these results suggest a hitherto unrecognized role for eosinophils in CM pathogenesis.
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Introduction
Cerebral malaria (CM) is the most severe outcome of Plasmodium
falciparum infection and a major cause of death in children
particularly from ages 2 to 4 years living in malaria endemic areas
and accounts for about 80% of fatal malaria cases [1]. To date, the
exact mechanism underlying the pathogenesis of CM remains
largely speculative. However, the observation that only 8 to 20%
of the 225 million annual malaria cases worldwide develop into
CM [2–3] suggests that, CM is a sub-population-specific targeted
syndrome. Several factors have been implicated in the develop-
ment of CM with both host and parasite genetics considered major
contributors. None of the two leading hypotheses proposed to
explain CM pathogenesis; the sequestration [4] and the inflam-
mation hypotheses [5] suggests a possible role for eosinophils and/
or their secretory products. On the other hand, several cells such
as red blood cells (RBCs), platelets, lymphocytes, neutrophils and
monocytes, their ligands and receptors have all been considered
potential contributors to CM pathogenesis mainly through their
participation in microvascular occlusion [6]. Consequently, the
greater number of CM immunogenetic studies have focused on
these cells and polymorphisms of endothelial cell surface receptors
known to interact with parasite factors on infected RBCs (iRBCs)
and the cytokines modulating the expression of these adhesion
molecules [6]. Indeed, polymorphisms in some of these molecules,
such as tumour necrosis factor (TNF)-a [7–9], interleukin (IL)-1b
[10–11], intercellular adhesion molecule (ICAM)-1 [10,12],
complement receptor (CR)-1 [10], IFN-c receptor 1 (IFNGR1)
[13], and inducible (iNOS), neuronal (nNOS) and endothelial
(eNOS) nitric oxide synthase [14–16] have been quite extensively
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studied for their association with CM but often with either no
association found or contradictory results. Eosinophils have
granules which contain four very basic, cytotoxic proteins;
eosinophil cationic protein (ECP), eosinophil peroxidase (EPO),
eosinophil-derived neurotoxin/eosinophil protein X (EDN/EPX)
and major basic protein (MBP) [17–18]. Both ECP and EDN have
neurotoxic properties with ECP being the more potent of the two
[18–19]. A hospital based study in Ghana involving CM patients
showed that P. falciparum infection induces eosinophilia and also
found a significantly higher level of ECP in CM patients than in
uncomplicated malaria (UM) and severe malarial anemia (SA)
patients [20]. Furthermore, an in vitro study has demonstrated that
ECP could inhibit P. falciparum growth in a dose-dependent
manner [21]. Thus, ECP might be important in the control of P.
falciparum infection but may also play a role in CM pathogenesis.
Here, we report the results of a hospital based malaria study with
population genetic data which supports the role of frequency
dependent selection genes involved in resistance or susceptibility to
infectious disease.
Single nucleotide polymorphisms (SNPs) have been described in
ECP (NP_002926.2), encoded by RNASE3 (NM_002935.2), which
alter both ECP serum levels [22] and function [23]. More
precisely, it has been shown that the c.371G.C polymorphism
(rs2073342) which results in an arginine to threonine amino acid
substitution (p.R124T) in the polypeptide and abolishes the
cytotoxicity of ECP and the G- and C-alleles have been associated
with allergic asthma [24] and helminth infections [25] respectively.
In addition, the 371C-allele was associated with non-allergic
asthma in a family-based study involving individuals from Norway
and the Netherlands [26]. Interestingly, in a more recent
publication [27], Jo¨nsson and colleagues found an association
with the 371GG genotype and non-allergic asthma in a cohort of
Swedes and Estonians, contradicting their previous findings [24].
However, this paradox may have been due to differences in the
methods used in characterizing patients in the two studies. Also,
the G-allele of the 39UTR c.*16G.C SNP, (rs2233860),
correlated with higher intracellular ECP [24] and was associated
with allergic rhinitis in Koreans [28]. Furthermore, a study in
India also found an association of the T-allele of the 39UTR
c.*94A.T, SNP (rs8019343) with helminth infection in one
patient [29]. In the present study, we have sequenced RNASE3 and
investigated the association between SNPs and susceptibility to
CM in a hospital based malaria study involving CM, SA and UM
patients. The population distribution of the CM associated -allele,
-genotype and -haplotype identified were also compared with that
of a non-malaria population (Danes) to investigate the extent of
possible selection due to CM. To our knowledge, this is the first
study in which polymorphisms in RNASE3 have been associated
with susceptibility to CM.
Methods
Ethics Statement
This study is part of a hospital based malaria study conducted at
Department of Child Health, Korle-Bu Teaching Hospital, Ghana
and the Noguchi Memorial Institute for Medical Research, Ghana
between 2002 and 2004. Ethical approval was given by the
Institutional Review Board of the Noguchi Memorial Institute for
Medical Research (NMIMR) and the Ethical Committee of the
University of Ghana Medical School, Korle-Bu, Ghana. Written
informed consent was given by the parents and guardians of
children before they were enrolled into the study. Ethical approval
for Danish blood donor samples was given by the Scientific Ethics
Committee of Copenhagen and Frederiksberg, Denmark.
Malaria patients
The study enrolled children from 0.5 to 13 years of age visiting
the Child Health Department of the Korle-Bu Teaching Hospital
(KBTH), Accra, for medical care during the study period. The
KBTH is the major referral hospital serving the southern part of
Ghana originally inhabited largely by the Akan and Ga-Adangbe
ethnic groups. A study involving individuals from the same study
area found no significant population substructure between the
Akan and Ga-Adangbe ethnic groups using data from 372
autosomal microsatellite loci [30]. The clinical and demographic
characteristics of the patients were as described elsewhere [31],
with some modifications (Table 1). Briefly, all patients had to be
febrile (.37.5uC measured within 24 hours of admission), sickle-
cell negative and slide positive for asexual Plasmodium falciparum
parasitaemia with at least some other sign of malaria such as
vomiting, diarrhoea, or malaise to be included in the study.
Altogether, 206 children were enrolled in the study, 45 of which
were CM cases, 56 had SA and 105 were UM cases. CM was
defined by unarousable coma (Blantyre coma score of ,3) [32],
with no other attributable cause of cerebral dysfunction; SA was
defined by measured haemoglobin (Hb) levels of ,5.0 g/dl with
no other attributable cause of anaemia and patients were fully
conscious. The criteria used to define UM was same as SA but
with a measured Hb of .6.0 g/dl. Thus, this group also includes
individuals with mild anaemia. The procedure used for determin-
ing parasitological and haematological parameters have been
described elsewhere [31]. Buffy coats were obtained from blood
samples taken from patients and stored at 280uC for DNA
purification.
Table 1. Clinical and demographic characteristics of patients with severe malaria and uncomplicated malaria.
Disease No. of Patients Hb (g/dl)T Age (yr)T Parasite Density (103/ml)T
CM 45 6.6 (2.5–10.2)**** 3.0 (0.5–10.0)** 41.4 (2.00–1,296)
SA 56 4.0 (2.1–4.9)**** 2.0 (0.5–12.0)**** 29.8 (0.01–1,411)*
UM 105 9.35 (6.1–13.0) 4.0 (0.5–13.0) 60.8 (0.137–4,340)
The number of patients in the various disease categories: cerebral malaria (CM), severe malaria anaemia (SA) and uncomplicated malaria (UM) is shown together with
haemoglobin (Hb) levels, age stratification and parasite density distribution.
TMedian values with minimum and maximum values (in parenthesis). Values that are statistically significant when compared to UM,
****p,0.0001,
**p= 0.0014,
*p= 0.0222.
doi:10.1371/journal.pone.0029465.t001
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Danish donors
In order to allow for inter-population comparison and analysis,
the study also used archived DNA samples purified from a panel of
anonymous Danish blood donors (n = 203) obtained for control
purposes. These 203 individuals, aged 17 to 67 years were of
Danish decent inhibiting central Copenhagen.
RNASE 3 gene sequencing
Genomic DNA was purified from buffy coat samples using the
MaxwellH16 system (Promega, Madison, USA). An approximate-
ly 1.5-kb fragment encompassing the promoter region and the
39UTR was amplified using the M13 (in lower case) tagged sense
primer (59- tgtaaaacgacggccagtGCCTGCCAGAGGACAGT-
TAT-39) and the antisense primer (59- caggaaacagctatgaccG-
GAGGAGTCAGTGGATGGAA-39) (Taq Copenhagen, Den-
mark) in a 25.0 ml reaction containing 40 ng genomic DNA,
10 mM of each primer, 1.25 mM of each dNTP, 1 unit of
HotStarTaqH DNA polymerase (Biomol, Germany) and the
corresponding 106HotStar reaction buffer. The PCR conditions
were 95uC activation for 15 minutes, 35 cycles of 95uC for
30 sec, 63uC for 45 sec, and 72uC for 1.40 s, with a final
extension at 72uC for 10 min. The product was then purified
using exonuclease 1 and alkaline phosphatase (ExoSap) reaction
and sequenced from both ends with M13 primers the internal
sense (59-CAGTTCTCACAGGAGCCACA-39) and antisense
(59-AGGTGAACTGGAACCACAGG-39) primers (Taq Copen-
hagen, Denmark) in a BigDyeH Terminator v3.1 (Applied
Biosystem, UK) reaction and analysed with the ABI 3730 DNA
Analyser (Applied Biosystem, UK). No significant difference was
observed when allele frequencies obtained in the hospital based
study were compared with those in a longitudinal malaria cohort
(n = 640) study of children (aged 1 to 13 years old) in which less
than 10% hospitalisation was recorded (Adu et al., unpublished
data). In order to verify the genotyping data a second PCR
was performed in which an approximately 1.7 kb product
encompassing the original primer sites was amplified from 96
randomly selected individuals, using the upstream sense (59-
tgtaaaacgacggccagtTCCTAACTACTATGCCTGCCTT-39) and
the downstream antisense (59-caggaaacagctatgaccTCAGCTGA-
TTCACTGCAGCTC-39) primers (Taq Copenhagen, Denmark).
Nucleotide sequencing of the resulting amplicons were in 100%
agreement with results obtained for these 96 individuals in the
original screen.
Statistical analysis
The clinical and demographic characteristics of the CM and SA
groups were compared to that of the UM group using the Mann
Whitney test as implemented in GraphPad Prism v.5.00
(GraphPad Software Inc. La Jolla, CA, USA). Similarly, coma
score distribution among the c.371G.C genotypes was compared
by the Mann Whitney test. Differences were considered to be
statistically significant if p,0.05. Haploview v. 4.2 (http://www.
broadinstitute.org/haploview) [33] was used to estimate deviations
of genotype frequencies from Hardy-Weinberg equilibrium
(HWE), visualize linkage disequilibrium (LD) patterns with
pairwise r2 values and define haplotypes. The adjusted p-value
for statistically significant differences in the HWE estimations was
p,0.0125 (correction factor = 4) according to the Boferroni
correction for multiple comparisons. RNASE3 allele and haplotype
frequencies in CM and UM patients were compared by multiple
logistic regression and adjusted for age and gender using S-Plus
2000 (Insightful Corporation, Seattle WA). There was no
statistically significant difference in the allele distribution between
SA and UM patients, hence the SA group was excluded from
haplotype association analysis. All the possible haplotypes present
in the population for the three closely linked SNPs were included
in the haplotype association studies. Comparison of haplotype
distribution between the Danish and Ghanaian populations was
by the chi-square (x2) test. DnaSP v. 5.10 (http://www.ub.edu/
dnasp/) [34] was used to estimate Tajima’s D to study evidence
of selection on the c.371G.C SNP in malaria versus non-malaria
endemic populations. To estimate the extent of divergence with
respect to this polymorphism in malaria endemic versus malaria
non-endemic populations, allele frequencies in our study
populations were compared to that of four populations namely,
the YRI: Yoruba in Ibadan, Nigeria; CEU: (Utah residents with
northern and western European ancestry from the Centre
d’Etude du Polymorphisme Humain [CEPH]); CHB: Han
Chinese in Beijing, China and JPT: Japanese in Tokyo, Japan
obtained from the International HapMap Project database
(http://hapmap.ncbi.nlm.nih.gov/cgiperl/snpdetails_phase3?name= rs2073342
&source= hapmap 28_B36&tmpl= snp_details_phase3). Pairwise FST
distances [35] were calculated for all 6 populations using the
POPTREE2 software [36].
Results
RNASE3 nucleotide sequence variation in Ghanaians
The RNASE3 gene and flanking regions were amplified from
206 Ghanaian children enrolled in a hospital based malaria
study. Nucleotide sequencing identified a total of six SNPs, one of
which was non-synonymous (c.371G.C; p.R124T) correspond-
ing to the previously described arginine/threonine polymorphism
which abolishes the cytotoxicity of ECP [23]. Of the remaining
SNPs, two (c.-5-43C.T, c.-5-38C.A) are located in the intron
and two (c.*16C.G, *94A.T), are located in the 39UTR
(Table 2). The last SNP, *295A.G is located downstream the
39UTR and was excluded from association analysis as was the c.-
5-38C.A polymorphism since the -5-38A-allele was only present
in a single individual. The remaining SNPs were all in Hardy-
Weinberg disequilibrium (Table 2) except the *295A.G (data
not shown).
Table 2. Allele frequencies and Hardy-Weinberg estimations in the CM and UM study populations.
Marker Alleles Location Amino acid change Minor allele (frequency) HWa p-value
rs2233858 c.-5-43C.T Intron - T (0.031) 8.7061023
rs2073342 c.371G.C Exon 2 Arg/Thr G (0.325) 1.0061024
rs2233860 c.*16G.C 39UTR - C (0.262) 4.1461028
rs8019343 c.*94A.T 39UTR - T (0.145) 5.9961027
avalues are statistically significant if p,0.0125 (Bonferroni corrected significance threshold).
doi:10.1371/journal.pone.0029465.t002
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Single marker and haplotype association study
An association study was carried out to assess the significance
of the four SNPs in CM (n = 45) and SA (n = 56) cases,
respectively. The two case groups were compared with the non-
severe control group comprising children suffering from UM
(n = 105) in a hierarchical multivariate logistic regression model
adjusting for age and gender. The 371G allele was found to be
significantly associated with CM (p= 0.00945, OR= 2.29, 95%
CI = 1.22–4.32) (Table 3) but not with SA (data not shown).
Linkage disequilibrium analysis demonstrated significant link-
age between the c.371G.C, c.*16C.G, and c.*94A.T SNPs
(Figure 1A), and haplotype analysis was therefore carried out to
determine their association with CM (Figure 1B). The
haplotype combination 371G/*16G/*94A was strongly associ-
ated with susceptibility to CM (p = 0.000913, OR= 4.14, 95%
CI = 1.79–9.56) (Figure 1B), thus, defining a risk haplotype
(GGA). The other haplotypes showed no significant association
with CM.
Association of c.371G.C genotypes with disease
To further assess the importance of the genotype forms of the
c.371G.C SNP in CM, the coma score was plotted for each of the
three genotypes. The mean coma score in individuals carrying the
371GG genotype was significantly lower as compared to the
371CC (Mann Whitney test, p=0.0022) and the 371CG (Mann
Whitney test, p=0.0394) genotypes respectively (Figure 2). On the
other hand, levels of parasitaemia did not differ significantly
between the three genotypes (data not shown).
Population differences
The above analyses suggest a strong association between the
371GG genotype and CM. It was therefore of interest to
Figure 1. Location of the studied SNPs in RNASE3, linkage disequilibrium (LD) patterns and haplotype association analysis. A) A
shematic of the region of the RNASE 3 gene (NM_002935.2) and LD plot of the respective SNPs visualised using Haploview v4.2. At the top of the LD
plot, the two exons are shown with the intron joining them. Untranslated regions of the exons are indicated by shadings. The LD plot shows pairwise
r2 values (6100) given in the squares for each comparison between the SNPs. White squares represent r2 values equal to 0. Different shades of grey
represent r2 values between 0 and 1. B) Haplotype associations with susceptibility to cerebral malaria (CM) compared to uncomplicated malaria (UM).
Odds ratio (OR) and 95% confidence intervals (CI) were determined using multivariate logistic regression controlling for age and gender. The
reference groups in the multivariate logistic regression analyses were those without the respective haplotypes. Haplotype 3 (GGA) was significanlty
associated with susceptibility to CM.
doi:10.1371/journal.pone.0029465.g001
Table 3. Single marker association with cerebral malaria and uncomplicated malaria.
Marker Alleles Associated Allele UM Freq. (n =105) CM Freq. (n =45) p - value OR (95% CI)
rs2233858 C/T T 0.03 0.04 9.4761021 1.05 (0.26–4.30)
rs2073342 C/G G 0.27 0.45 9.4561023 2.29 (1.22–4.32)
rs2233860 G/C G 0.72 0.81 4.9461021 1.22 (0.68–2.21)
rs8019343 A/T T 0.14 0.16 1.3761021 0.53 (0.22–1.24)
The frequency of the associated allele in uncomplicated malaria (UM) and CM is shown. Odds Ratios (OR) and 95% confidence intervals (CI) were determined using
multivariate logistic regression controlling for age and gender. The reference groups in the multivariate logistic regression analyses were those without the respective
alleles.
doi:10.1371/journal.pone.0029465.t003
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investigate the differences in the genotype distribution of
c.371G.C between populations from malaria versus non-malaria
endemic regions. RNASE3 and flanking regions were amplified
from Danish blood donors (n = 203). Sequencing analysis
identified all the SNPs found in the Ghanaian samples plus a
novel SNP (c.214C.T) in exon 2 resulting in an arginine to
cysteine polymorphism at position 72. In contrast to the Ghanaian
samples, all SNPs in the Danish samples were in Hardy-Weinberg
equilibrium (p.0.0125). There was a statistically significant
difference in the distribution of both the 371GC genotypes
(p,0.0001, x2-test) and alleles (p,0.0001, x2-test) in the Ghanaian
and Danish populations (Figure 3B and 3C). The c.371G.C allele
distributions were compared to those reported in the International
HapMap project database. The 371C allele is dominating in
individuals from malaria endemic regions (Ghanaians and YRI)
whereas the 371G allele is dominating in individuals from malaria
non-endemic populations (CEU, CHB and JPT) (Figure 3C).
Pairwise FST calculations showed a significant genetic divergence
between individuals from malaria endemic (Ghanaians and YRI)
and malaria non-endemic areas (Danes, CEU, CHB and JPT)
(0.2040#FST$0.3520) (Table 4). On the other hand, the data
showed no significant evidence of population divergence between
the Ghanaians and the YRI individuals or among the Danes,
CEU, CHB and JPT (Table 4). The distribution of the haplotypes
defined by the markers, rs2073342, rs2233860 and rs8019343
were also significantly different (p=0.0010, x2-test for trends)
between the populations. Interestingly, the most predominant
haplotype in the Danish population was the CM-risk associated
haplotype seen in the Ghanaian association studies (Figure 3A).
The c.371G.C genotype is subject to selection pressure
To investigate the selective pressures operating on the
RNASE3, we performed a sliding-window analysis of Tajima’s
D values across the aligned RNASE3 sequences for Ghanaians
and Danes respectively (Figure 4). This analysis identified a
region in RNASE3 (nucleotides 776–950) that exhibited a nearly
significant departure from 0 in the Ghanaians population
(D= 1.80; p,0.1), indicating that frequency-dependent selection
was operating at the c.371G.C SNP.
Discussion
The findings reported here, together with the observation that
levels of ECP increase during acute malaria [20] strongly suggest a
role for eosinophils in CM pathogenesis.
Firstly, we have shown that the cytotoxic G-allele of the
previously described functional (c.371G.C) polymorphism
(rs2073342) of RNASE3 predisposes to CM in Ghanaian children
and we have identified a risk associated haplotype, GGA including
this G-allele together with the G-allele of rs2233860 which is
associated with increased levels of soluble ECP, and the A-allele of
rs8019343. Secondly, the Tajima’s D test showed a positive
departure from neutrality in the RNASE3 region encompassing the
functional c.371G.C polymorphism. Frequency dependent
selection may be a plausible explanation for this phenomenon.
Mutations that arise in the population and have the potential to
eliminate the toxic activity of ECP may have a survival advantage,
leading to their increased frequency in the population. Thirdly, the
frequency of the G-allele of the (c.371G.C) polymorphism in the
African populations (Ghanaians and the YRI) is significantly
reduced compared to non-malarial population (Danes and CEU;
CHB and JPT). This finding is in line with the evidence of
diversifying selection on the c.371G.C polymorphism and
suggests that malaria exerts a strong selection pressure on ECP.
Fourthly, c.371G.C and the other SNPs forming the risk
haplotype are all in Hardy-Weinberg disequilibrium in the African
samples whereas they are in Hardy-Weinberg equilibrium in the
Danish samples. Uncharacterised SNPs, insertions or deletions
near the 39 end of a primer may often cause failure in allele
amplification [37] and can result in genotype frequency deviations
from Hardy-Weinberg equilibrium. However, this is an unlikely
explanation for the Hardy-Weinberg disequilibrium observed
because DNA sequencing of a larger amplicon revealed no
uncharacterised SNPs, insertions or deletions in the initial primer
binding regions. Taken together, these findings have led us to
propose that ECP and eosinophils are involved in CM
pathogenesis. Cerebral malaria pathogenesis is still not clearly
understood, however, emerging evidence suggests the possibility
that IgE-mediated allergic response or atopy may be risk factors.
The chromosome 5q31 locus which has been linked to blood P.
falciparum parasites density [38] also contains the genes encoding
the cytokines IL-4, IL-5, and IL-13, and these have been
associated with inflammatory diseases including asthma [39]. IL-
5 is a potent activator of eosinophils [40] and together with the
elevated IgE levels typically associated with CM [41] might
amplify eosinophil-mediated cytotoxicity by ECP against both
parasite and host cells.
Studies have shown that ECP efficiently kills some parasites
including P. falciparum, in vitro [21,42], but the toxic properties of
ECP may also lead to tissue damage within the host in conditions
such as asthma [43]. The toxic property of ECP is also well
documented on several human cell lines, in vitro, including
epithelial cells [23,44–45]. Although the mechanisms of its
cytotoxicity are not fully understood, it has been shown that the
371CC genotype encodes a non-toxic form of ECP [45]. This has
been demonstrated using both native ECP and recombinant ECP
expressed in several expression systems [23,44–45]. The most
Figure 2. Association of c.371G.C genotypes with coma score in
the entire patient population studied. Coma score distribution
among individuals with 371 (GG, GC and CC) genotypes is shown.
Comparisons that yielded statistical significance are indicated with
horizontal lines linking the respective groups at the top of the plots with
the p – value stated. P-values were determined byMannWhitney test and
horizontal lines within plots represent the median of the distribution.
doi:10.1371/journal.pone.0029465.g002
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likely explanation for this change in cytotoxic activity could be that
the substitution of arginine with threonine creates a potentially
new glycosylation site in ECP. Indeed Trulson et al [23]
demonstrated that the noncytotoxic rECP124thr regained the
cytotoxic activity after deglycosylation. Kurtzhals and colleagues
observed that ECP plasma levels increased in acute P. falciparum
infection particularly in CM patients but peripheral eosinophil
counts were curiously low. Consequently, they speculated that the
low eosinophil counts in these patients may be due to eosinophil
destruction or tissue sequestration rather than a decrease in their
production [20]. Here we propose that peripheral eosinophils
migrate to the post capillary venules during CM where they
adhere to intracellular adhesion molecule (ICAM)-1 or other
endothelial cellular adhesion molecules (eCAMs) which become
up-regulated during CM [46]. Upon binding to (ICAM)-1 through
their Beta2 (CD18) integrins, eosinophils release ECP [47] which
increases the expression of (ICAM)-1 as demonstrated in nasal
epithelia cells [48] suggesting that it might mediate a positive feed-
back mechanism. ECP may also be released from eosinophils
through stimulation with platelet activating factor (PAF) [49]
which is also a potent stimulator of eosinophil adherence [50].
Platelets have recently been proposed to play a central role in the
activation of pathogenic inflammation [51], thus PAF might
indirectly mediate inflammation through stimulation of eosinophil
adherence to the capillaries and the subsequent release of ECP.
Knowing that ECP is cytotoxic and may induce necrosis in human
primary epithelial cells, we suggest that the release of ECP,
together with pro-inflammatory cytokines, may lead to epithelia
damage of the capillaries and possibly vascular leakage. Petechial
Figure 3. RNASE3 haplotypes, c.371G.C genotypes and alleles distribution in malaria endemic (Ghanaian) versus non-malaria (Danish)
populations. A) Distribution of haplotypes defined by the three SNPs (rs2073342, rs2233860 and rs8019343) as from block 1 in Figure 1A in the two
populations. B) c.371G.C genotype distribution in all Ghanaian subjects compared to Danes. C) c.371G.C allelic distribution in the two populations.
doi:10.1371/journal.pone.0029465.g003
Table 4. Pairwise genetic distances between 6 populations
compared.
Group YRI* Danes CEU* CHB* JPT*
Ghanaian 0.0060 0.2900 0.3520 0.2600 0.3330
YRI* 0.2330 0.2940 0.2040 0.2750
Danes 0.0060 0.0020 0.0030
CEU* 0.0140 0.0010
CHB* 0.0090
FST distance (Latter et al., 1972).
*Allele frequency data for the c.371G.C polymorphism for these populations
were retrieved from the International HapMap Project database (http://hapmap.
ncbi.nlm.nih.gov/cgi- perl/snp_details_phase3?name= rs2073342&source = hapmap
28_B36&tmpl = snp_details_phase3). YRI: Yoruba in Ibadan, Nigeria; CEU: (Utah
residents with northern and western European ancestry from the Centre d’Etude
du Polymorphisme Humain [CEPH]); CHB: Han Chinese from Beijing, China and
JPT: Japanese.
doi:10.1371/journal.pone.0029465.t004
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hemorrhaging into the brain is considered a hallmark of CM [52],
although the exact contribution of vascular leakage to CM is not
known [53].
As the blood-brain barrier becomes compromised during CM,
ECP and other plasma proteins may leak into the interstitial space.
ECP has been shown to elicit the Gordon phenomenon when
injected intracathecally into rabbits, mainly due to its profound
neurotoxic effect on the cerebellum compared to other nervous
tissue in animal models [19]. Thus, ECP may account for some of
the typical cerebellar symptoms observed in CM. In the present
study, 371GG which codes for the more cytotoxic and ancestral
form of ECP [54] was significantly associated with both CM and
low Blantyre coma score. The Blantyre coma score is defined by;
(best motor response score) + (best verbal response score) + (eye
movement score) [32]; parameters which are largely under the
control of the cerebellum [55], suggesting that lower coma scores
which typify poor CM prognosis may be a consequence of
cerebellar dysfunction due to ECP neurotoxicity. This implies,
both ECP neurotoxicity as well as cytotoxicity are either stronger
in the native protein (ECP124arg) than in the mutant form
ECP124thr or fully lost in the mutant since the later was not
associated with CM and was only occasionally associated with
lower coma scores in the present study.
In the present study we found a large difference between
African and non-African samples as exemplified by the
distribution of the c.371G.C genotype. The 371CC genotype
was dominant in the Ghanaian samples compared to Danish
samples (56% vs. 12%) while the opposite was observed for the
371GG genotype (15% vs 53%). This finding is consistent with
data for four populations from the International HapMap Project
database and also with other studies where this SNP was
quantified in samples from Uganda, Sudan, and Sweden [25].
Likewise, the CM associated GGA haplotype was the most
common haplotype found in 69% of the Danish samples, whereas
it was only found in 18% of the Ghanaian samples. The risk
haplotype GGA implies higher intracellular content of cytotoxic
ECP and whereas this may crucial in controlling certain
infections such as helminths it may also contribute to severe
pathology in P. falciparum infections as shown in the present study.
The high prevalence of the CM associated allele and haplotype in
the European population implies a greater than 3 fold likelihood
of a European developing CM compared to a Ghanaian if an
infection with P. falciparum is not treated timely. Conversely, the
CGA haplotype was quite uncommon in the Danish samples, but
found among 42% of the Ghanaian samples. The most likely
explanation for these differences is natural selection e.g.
frequency-dependent selection on the c.371G.C SNP. Eriksen
et al hypothesized that the predominance of the 371CC genotype
is due to positive selection exerted by Schistosoma mansoni [25].
However, mortality due to S. Mansoni is usually more common in
older individuals whereas mortality due to CM is more common
in children than in adults. Thus, P. falciparum malaria is a more
likely cause for the predominance of the C-allele in African
populations than S. Mansoni. In fact, as the 371CC genotype
codes for the non-cytotoxic form of ECP, malaria-endemic
populations may be relatively more susceptible to other parasitic
infections such as S. Mansoni where cytotoxic ECP play a
protective role [25]. Thus, ECP may represent an example where
one parasite is selecting for a protein variant which makes the
same population more susceptible to other parasites. The
relatively small sample size might be a limitation in our study.
However, the 371G allele frequencies reported here in the
present study agrees well with those reported for other
populations from malaria endemic areas of East-Africa [25]
and with data from the International HapMap Project database,
supporting the notion that malaria exerts a strong selection
pressure to eliminate the cytotoxic form of ECP. In conclusion,
we have identified an association between the 371G allele of
RNASE3 and susceptibility to CM and a risk associated
haplotype GGA defined by the markers: rs2073342 (G-allele),
rs2233860 (G-allele) and rs8019343 (A-allele) respectively. We
have also shown that the RNASE3 371GG genotype is subject to
selection pressure and we suggest that the predominance of the
371C allele results from a strong selection pressure by P.
falciparum malaria in endemic populations. Collectively, our
results suggest a hitherto unrecognized role for eosinophils in
CM pathogenesis.
Figure 4. Tajima’s D index . Sliding window analysis of Tajima’s D
index across the Ghanaian (A) and Danish (B) RNASE3 sequences. Bar at
the top shows the sequence region analyzed (nucleotides 1–1183) and
the positions of the SNP. Window sizes used were 100 bp with a 25-bp
step size. Windows that gave a significant D value p,0.10), are
indicated above the relevant window midpoint by a hash (#).
doi:10.1371/journal.pone.0029465.g004
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